Axsome Therapeutics Announces FDA Approval of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in Adults
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Nasdaq, S&P 500 slip from record highs as yields and oil rebound
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
| (NASDAQ: AXSM) | Delayed: 173.58 -0.76 (0.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $174.34 | 52 Week High | $15.74 | |||
| Open | $174.00 | 52 Week Low | $5.37 | |||
| Day High | $174.48 | P/E | N/A | |||
| Day Low | $172.62 | EPS | $0.00 | |||
| Volume | 148,987 | |||||
